Literature DB >> 21127175

Infection in infancy and subsequent risk of developing lymphoma in children and young adults.

Lynn R Goldin1, Ola Landgren, Sigurdur Y Kristinsson, Magnus Björkholm, Ora Paltiel.   

Abstract

There is evidence that certain infections and autoimmunity predispose to the development of non-Hodgkin lymphomas (NHLs). A previous study reported that hospitalization for infections in infancy led to an increased risk of NHL. By using population-based registries in Sweden, we compared the rate of hospitalization for infections in infancy between lymphoma cases and matched controls for patients born since 1964. A history of infection was associated with a significantly increased risk of aggressive B-cell lymphomas (odds ratio 2.1, 95% confidence interval 1.11-4.04, P = .02). The specific infections involved were respiratory and intestinal. No effects were observed among cases of Hodgkin lymphoma. This association could result from the infection, its treatment, or could be a surrogate marker for underlying immune defects. Further studies are needed to determine whether this association is present among NHL occurring in older adults and if improved survival of patients with immune defects has contributed to the secular increases in incidence of NHLs.

Entities:  

Mesh:

Year:  2010        PMID: 21127175      PMCID: PMC3056592          DOI: 10.1182/blood-2010-09-306274

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Altered immunity as a risk factor for non-Hodgkin lymphoma.

Authors:  Andrew E Grulich; Claire M Vajdic; Wendy Cozen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03-02       Impact factor: 4.254

Review 2.  Bacteria and early human development.

Authors:  Mark Wilks
Journal:  Early Hum Dev       Date:  2007-02-07       Impact factor: 2.079

3.  From idiopathic infectious diseases to novel primary immunodeficiencies.

Authors:  Jean-Laurent Casanova; Claire Fieschi; Jacinta Bustamante; Janine Reichenbach; Natasha Remus; Horst von Bernuth; Capucine Picard
Journal:  J Allergy Clin Immunol       Date:  2005-08       Impact factor: 10.793

4.  Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.

Authors:  Sigurdur Y Kristinsson; Jill Koshiol; Magnus Björkholm; Lynn R Goldin; Mary L McMaster; Ingemar Turesson; Ola Landgren
Journal:  J Natl Cancer Inst       Date:  2010-02-24       Impact factor: 13.506

5.  The risk of cancer following hospitalization for infection in infancy: a population-based cohort study.

Authors:  Ora Paltiel; David E Laniado; Rivlca Yanetz; Lisa Deutsch; Ronit Calderon-Margalit; Susan Harlap; Yehiel Friedlander
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-10       Impact factor: 4.254

Review 6.  Infectious agents as causes of non-Hodgkin lymphoma.

Authors:  Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03-02       Impact factor: 4.254

7.  Changing incidence of non-Hodgkin lymphomas in the United States.

Authors:  Christina A Clarke; Sally L Glaser
Journal:  Cancer       Date:  2002-04-01       Impact factor: 6.860

8.  Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies.

Authors:  Keitaro Matsuo; Aaron Kusano; Aravind Sugumar; Shigeo Nakamura; Kazuo Tajima; Nancy E Mueller
Journal:  Cancer Sci       Date:  2004-09       Impact factor: 6.716

9.  Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003.

Authors:  Ingemar Turesson; Martha S Linet; Magnus Björkholm; Sigurdur Y Kristinsson; Lynn R Goldin; Neil E Caporaso; Ola Landgren
Journal:  Int J Cancer       Date:  2007-11-15       Impact factor: 7.396

Review 10.  Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms.

Authors:  Tahseen Al-Saleem; Hamid Al-Mondhiry
Journal:  Blood       Date:  2004-11-12       Impact factor: 22.113

View more
  3 in total

1.  Hodgkin lymphoma risk following infectious and chronic inflammatory diseases: a large population-based case-control study from Sweden.

Authors:  Sigurdur Y Kristinsson; Ying Gao; Magnus Björkholm; Sigrun Helga Lund; Jan Sjöberg; Neil Caporaso; Lynn R Goldin; Ola Landgren
Journal:  Int J Hematol       Date:  2015-03-11       Impact factor: 2.490

2.  Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study.

Authors:  Amy M Linabery; Erik B Erhardt; Rachel K Fonstad; Richard F Ambinder; Greta R Bunin; Julie A Ross; Logan G Spector; Seymour Grufferman
Journal:  Int J Cancer       Date:  2014-03-18       Impact factor: 7.396

Review 3.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.

Authors:  Tobias R Kollmann; Ofer Levy; Ruth R Montgomery; Stanislas Goriely
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.